These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke. Ciccone A; Valvassori L; Nichelatti M; Int J Stroke; 2011 Jun; 6(3):259-65. PubMed ID: 21557814 [TBL] [Abstract][Full Text] [Related]
4. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152 [TBL] [Abstract][Full Text] [Related]
5. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan. Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704 [TBL] [Abstract][Full Text] [Related]
8. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator. Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898 [TBL] [Abstract][Full Text] [Related]
17. Treating as early as possible with thrombolysis is crucial, but can we do better in the sub-4.5-hour time window? Parsons MW Cerebrovasc Dis; 2011; 31(3):229. PubMed ID: 21178346 [No Abstract] [Full Text] [Related]
18. Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset? Kent DM; Ruthazer R; Selker HP Stroke; 2003 Feb; 34(2):464-7. PubMed ID: 12574561 [TBL] [Abstract][Full Text] [Related]
19. Intravenous thrombolysis for acute ischaemic stroke: preliminary experience with recombinant tissue plasminogen activator in the UK. Walters MR; Muir KW; Harbison J; Lees KR; Ford GA Cerebrovasc Dis; 2005; 20(6):438-42. PubMed ID: 16230848 [TBL] [Abstract][Full Text] [Related]
20. Optimal timing of thrombolytic therapy in acute ischaemic stroke. Madden K CNS Drugs; 2002; 16(4):213-8. PubMed ID: 11945105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]